Based on your answers, the best fit for you seems to be: DEXCOM ONE.
These results are only recommendations. Always consult your provider before stopping, starting, or modifying any treatment.
The Dexcom ONE Continuous Glucose Monitoring (CGM) system is our smart and easy real-time CGM system designed to provide essential glucose insights for more confident treatment decisions.
Key Features include:
✓ Customisable high and low alerts to know when to take action
✓ Delay 1st Alert designed to avoid alert fatigue
✓ All-in-one app with real-time monitoring and long-term results
✓ Optional receiver available
✓ Delay 1st Alert designed to avoid alert fatigue
✓ All-in-one app with real-time monitoring and long-term results
✓ Optional receiver available
If you’re looking to connect an insulin pump or pen, we invite you to take a look at Dexcom G6.
If you’re seeking a remote monitoring option for your circle of care, we invite you to take a look at Dexcom G7.
If you’re seeking a remote monitoring option for your circle of care, we invite you to take a look at Dexcom G7.
Want to take a deeper dive? Compare our CGM systems.
The Dexcom CGM Difference
Real-time readings
Accurate glucose numbers at a glance,8 easily accessible on a compatible smart device or receiver*
Reliable insights
Confident treatment decisions, even when glucose is changing rapidly8
Lifestyle flexibility
Customizable alarms and partner connections adapt to your needs and lifestyle
Proven results
Lowers HbA1c, reduces highs and lows, and improves quality of life1-5
Loved by users
A growing number of happy users: 90% of users intend to stay on Dexcom6,7
*Compatible smart devices sold separately: dexcom.com/compatibility. Optional Receiver sold separately.
8 Shah V LL, et al. Diabetes Technol and Ther. 2018;20(6).
1 Beck RW, et al. JAMA. 2017;317(4):371-378.
2 Welsh JB, et al. J Diabetes Sci Technol. 2022. doi:10.1177/19322968221099879.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel L, et al. JAMA. 2020;323(23):2388-2396.
6 Based on use out of 30 days.
7 Seagrove Patient Perspectives, 2020.